Search Results - "SCANLON, Kevin"

Refine Results
  1. 1

    Anti-genes: siRNA, ribozymes and antisense by Scanlon, Kevin J

    Published in Current pharmaceutical biotechnology (01-10-2004)
    “…Scientists have been working on strategies to selectively turn off specific genes in diseased tissues for the past thirty years. In the 1980's,…”
    Get more information
    Journal Article
  2. 2

    Cancer Gene Therapy: Challenges and Opportunities by SCANLON, Kevin J

    Published in Anticancer research (01-03-2004)
    “…Understanding the molecular basis of human disease has been the corner-stone of rationally designed molecular therapies. Medicine has a long history of…”
    Get full text
    Journal Article
  3. 3

    Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer by Kijima, Hiroshi, Yamazaki, Hitoshi, Nakamura, Masato, Scanlon, Kevin J, Osamura, R Yoshiyuki, Ueyama, Yoshito

    Published in International journal of oncology (01-03-2004)
    “…Point mutations in the K-ras gene are observed at a high incidence in human pancreatic carcinomas. These alterations can be used as potential targets for…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme by MAELANDSMO, G. M, HOVIG, E, SKREDE, M, ENGEBRAATEN, O, FLØRENES, V. A, MYKLEBOST, O, GRIGORIAN, M, LUKANIDIN, E, SCANLON, K. J, FODSTAD, Ø

    Published in Cancer research (Chicago, Ill.) (01-12-1996)
    “…The putative role of the CAPL gene in enhancing the development of human cancer metastasis was examined by transfecting human high-expressing osteosarcoma…”
    Get full text
    Journal Article
  6. 6

    Commercializing medical technology by Scanlon, Kevin J, Lieberman, Mark A

    Published in Cytotechnology (Dordrecht) (01-04-2007)
    “…As medicine moves into the 21st century, life saving therapies will move from inception into medical products faster if there is a better synergy between…”
    Get full text
    Journal Article
  7. 7

    Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme by FENG, M, CABRERA, G, DESHANE, J, SCANLON, K. J, CURIEL, D. T

    Published in Cancer research (Chicago, Ill.) (15-05-1995)
    “…Strategies have been developed to abrogate the aberrant expression of dominant oncogenes as a means to accomplish targeted tumor eradication. We have…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Relevance of Ethical Standards among Veteran Superintendents by Scanlon, Kevin

    Published 01-01-2022
    “…Ethical violations in education exist worldwide. Superintendents of schools are in the unique position of exerting their authority and influence on the entire…”
    Get full text
    Dissertation
  10. 10

    Ribozyme-Mediated Reversal of the Multidrug-Resistant Phenotype by Scanlon, Kevin J., Ishida, Hironori, Kashani-Sabet, Mohammed

    “…This study examined the effects of suppressing c-fos oncogene expression on multidrug resistance (MDR). A2780S human ovarian carcinoma cells with resistance to…”
    Get full text
    Journal Article
  11. 11

    Construction and Transfection of a Ribozyme Targeting Human Caspase-3 by CRONIN, Deirdre, DALY, Carmel, O'DOHERTY, Toni, HEENAN, Mary, SCANLON, Kevin J, CLYNES, Martin

    Published in Anticancer research (01-03-2004)
    “…Caspase-3 is a key executioner cysteine protease involved in programmed cell death or apoptosis. A ribozyme to human caspase-3 was designed, tested by in vitro…”
    Get full text
    Journal Article
  12. 12

    Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme by MOHAMMED KASHANI-SABET, FUNATO, T, FLORENES, V. A, FODSTAD, O, SCANLON, K. J

    Published in Cancer research (Chicago, Ill.) (15-02-1994)
    “…In this study, the efficacy of an anti-ras ribozyme in reversing the neoplastic phenotype was investigated. Murine NIH3T3 cells were transfected with cellular…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Ribozyme as an approach for growth suppression of human pancreatic cancer by KIJIMA, H, SCANLON, K. J

    Published in Molecular biotechnology (2000)
    “…Ribozymes (catalytic RNAs, RNA enzymes) are effective modulators of gene expression because of their simple structure, site-specific cleavage activity, and…”
    Get full text
    Journal Article
  15. 15

    Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells by Funato, T, Ishii, T, Kambe, M, Scanlon, K J, Sasaki, T

    Published in Cancer gene therapy (01-03-2000)
    “…Colon cancer is one of the carcinomas that is resistant to a variety of therapies. To develop a new therapy by regulating the activated K-ras gene in colon…”
    Get full text
    Journal Article
  16. 16

    Ribozymes as Therapeutic Agents: Are We Getting Closer? by Scanlon, Kevin J., Kashani-Sabet, Mohammed

    “…An editorial addresses a study by Yamazaki et al in which they extend the utility of ribozymes for target validation in human cancer. A hammerhead ribozyme…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate by HILL, B. T, SHELLARD, S. A, HOSKING, L. K, DEMPKE, W. C. M, FICHTINGER, A. M. J, TAKESHI, S, TONE, T, SCANLON, K. J, WHELAN, R. D. H

    Published in Cancer research (Chicago, Ill.) (01-06-1992)
    “…In vitro exposure of the TR170 ovarian carcinoma cell line to six intermittent 24-h treatments with a 90% inhibitory concentration of cisplatin (CDDP) (0.15…”
    Get full text
    Journal Article
  19. 19

    Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro by OHNUMA, T, LO, R. J, SCANLON, K. J, KAMEN, B. A, OHNOSHI, T, WOLMAN, S. R, HOLLAND, J. F

    Published in Cancer research (Chicago, Ill.) (01-04-1985)
    “…A human acute lymphoblastic T-cell line, MOLT-3, was fed with Roswell Park Memorial Institute Medium 1640 supplemented with 10% fetal bovine serum and…”
    Get full text
    Journal Article
  20. 20